ASMBS Position Statement on the Impact of Metabolic and Bariatric Surgery on Nonalcoholic Steatohepatitis
The following position statement is issued by the American Society for Metabolic and Bariatric Surgery in response to inquiries made to the Society by patients, physicians, society members, hospitals, health insurance payors, the media, and others, regarding the impact of Metabolic and Bariatric Surgery (MBS) on nonalcoholic fatty liver disease, specifically for Laparoscopic Roux-en-Y gastric bypass (LRYGB) and Laparoscopic Sleeve Gastrectomy (LSG). The general principles described here may also apply to other procedures; however, the paucity of procedure-specific literature limits the value of this statement beyond these procedures.
Source: Surgery for Obesity and Related Diseases - Category: Surgery Authors: Guilherme S. Mazzini, Toms Augustin, Sabrena Noria, Carlos Romero-Marrero, Na Li, Bilal Hameed, Dan Eisenberg, Dan E. Azagury, Sayeed Ikramuddin Tags: Original articles Source Type: research
More News: Bariatric Surgery | Eating Disorders & Weight Management | Fatty Liver Disease (FLD) | Gastrectomy | Gastric Bypass | Gastroenterology | Health Insurance | Hospitals | Insurance | Laparoscopy | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Surgery | Urology & Nephrology